Save time and get answers to complex questions with AI chat
Defense strategy against generic in niche market?Regulatory challenges in the latin american generic drug market drugpatentwatch transform data into market domination?Guselkumab brand name?Are there specific stretches to avoid while on lipitor?Pramlintide acetate price?
See the DrugPatentWatch profile for xarelto
Xarelto (rivaroxaban) was first approved and launched in the U.S. in 2011. [1]
“Xarelto” has had multiple follow-on approvals for additional uses and different dosing/formulations over time, but the core drug (rivaroxaban) came to market in 2011. [1]
If by “come out” you mean when generic or biosimilar-style competition could start, that depends on the specific patent/exclusivity for the particular product and jurisdiction. DrugPatentWatch.com tracks these patent/exclusivity details by drug. [2]
[1] https://www.drugs.com/history/xarelto.html [2] https://www.drugpatentwatch.com/
Other Questions About Xarelto :